Additionally, the 36-month beta value for CELZ is 4.69. There are mixed opinions on the stock, with 0 analysts rating it as a “buy,” 1 rating it as “overweight,” 0 rating it as “hold,” and 0 rating it as “sell.”
The public float for CELZ is 1.71M and currently, short sellers hold a 2.36% ratio of that float. The average trading volume of CELZ on February 20, 2025 was 53.53K shares.
CELZ) stock’s latest price update
Creative Medical Technology Holdings Inc (NASDAQ: CELZ)’s stock price has soared by 26.80 in relation to previous closing price of 4.85. Nevertheless, the company has seen a gain of 57.29% in its stock price over the last five trading days. globenewswire.com reported 2025-02-14 that PHOENIX, Feb. 14, 2025 (GLOBE NEWSWIRE) — Creative Medical Technology Holdings, Inc. (“Creative Medical Technology” or the “Company”) (NASDAQ: CELZ), a pioneering biotechnology firm specializing in regenerative medicine solutions for immunotherapy, endocrinology, urology, gynecology, and orthopedics, today announced compelling mid-term follow-up data from its StemSpine® pilot study utilizing its AlloStem™ cells for the treatment of chronic lower back pain. The pilot study demonstrated a substantial reduction in opioid dependency and significant improvements in pain levels and functional mobility.
CELZ’s Market Performance
Creative Medical Technology Holdings Inc (CELZ) has experienced a 57.29% rise in stock performance for the past week, with a 170.93% rise in the past month, and a 131.20% rise in the past quarter. The volatility ratio for the week is 20.85%, and the volatility levels for the past 30 days are at 16.26% for CELZ. The simple moving average for the past 20 days is 67.57% for CELZ’s stock, with a 81.06% simple moving average for the past 200 days.
CELZ Trading at 116.37% from the 50-Day Moving Average
After a stumble in the market that brought CELZ to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -40.18% of loss for the given period.
Volatility was left at 16.26%, however, over the last 30 days, the volatility rate increased by 20.85%, as shares surge +165.66% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading +153.09% upper at present.
During the last 5 trading sessions, CELZ rose by +57.29%, which changed the moving average for the period of 200-days by +34.43% in comparison to the 20-day moving average, which settled at $3.67. In addition, Creative Medical Technology Holdings Inc saw 166.23% in overturn over a single year, with a tendency to cut further gains.
Stock Fundamentals for CELZ
Current profitability levels for the company are sitting at:
- -511.82 for the present operating margin
- -7.04 for the gross margin
The net margin for Creative Medical Technology Holdings Inc stands at -483.45. The total capital return value is set at -0.86. Equity return is now at value -57.03, with -54.82 for asset returns.
Currently, EBITDA for the company is -5.53 million with net debt to EBITDA at 1.15. When we switch over and look at the enterprise to sales, we see a ratio of 408.07. The liquidity ratio also appears to be rather interesting for investors as it stands at 19.13.
Conclusion
In conclusion, Creative Medical Technology Holdings Inc (CELZ) has seen better performance in recent times. Analysts have a mixed opinion on the stock, with some rating it as a “buy” and others rating it as a “hold”. It is worth mentioning that the stock is currently trading in close proximity to its 50-day moving average and its 52-week high.
